Provided by Tiger Trade Technology Pte. Ltd.

Bioventus Inc.

14.02
-0.3600-2.50%
Post-market: 14.020.00000.00%19:30 EDT
Volume:669.50K
Turnover:9.44M
Market Cap:1.18B
PE:17.93
High:14.55
Open:14.42
Low:13.93
Close:14.38
52wk High:15.89
52wk Low:6.26
Shares:84.09M
Float Shares:33.47M
Volume Ratio:1.06
T/O Rate:2.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7821
EPS(LYR):0.3300
ROE:25.68%
ROA:5.49%
PB:5.16
PE(LYR):42.48

Loading ...

Bioventus Earnings Call Signals Profitable Growth Ahead

TIPRANKS
·
Mar 10

Bioventus management to meet with Barrington

TIPRANKS
·
Mar 10

Bioventus Is Maintained at Buy by Craig-Hallum

Dow Jones
·
Mar 07

Bioventus price target raised to $14 from $13 at Barrington

TIPRANKS
·
Mar 06

Canaccord Genuity Sticks to Its Buy Rating for Bioventus (BVS)

TIPRANKS
·
Mar 06

Bioventus Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 05

BUZZ-U.S. STOCKS ON THE MOVE -Burlington Stores, Berkshire Hathaway, Bioventus

Reuters
·
Mar 05

BUZZ-Bioventus rises after better-than-expected quarterly results

Reuters
·
Mar 05

Bioventus sees FY26 adjusted EPS 73c-77c, consensus 77c

TIPRANKS
·
Mar 05

Bioventus beats Q4 revenue estimates on strong demand for pain treatments and surgical solutions

Reuters
·
Mar 05

Bioventus Q4 cash from operations jumps 97% to USD 38 million

Reuters
·
Mar 05

Bioventus Q4 2025 Adj. EPS $0.24 Beats $0.22 Estimate, Sales $157.900M Beat $154.847M Estimate

Benzinga Earnings
·
Mar 05

BRIEF-Bioventus Q4 Adjusted EPS USD 0.24

Reuters
·
Mar 05

Bioventus Inc Outlook FY Net Sales of $600 Million to $610 Million

THOMSON REUTERS
·
Mar 05

Bioventus Inc Outlook FY Adjusted EPS of $0.73 to $0.77

THOMSON REUTERS
·
Mar 05

Press Release: Bioventus Announces Fourth Quarter and Full Year 2025 Financial Results

Dow Jones
·
Mar 05

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 05

Top News Today: Stocks Gain as Economic Data Offsets War Fears

Dow Jones
·
Mar 05

Bioventus Inc expected to post earnings of 22 cents a share - Earnings Preview

Reuters
·
Mar 03

Analysts Have Conflicting Sentiments on These Healthcare Companies: Henry Schein (HSIC), Dyadic International (DYAI) and Bioventus (BVS)

TIPRANKS
·
Mar 02